CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AURA BIOSCIENCES INC ownership

AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 1 filers reported holding AURA BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AURA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$652,325
-27.4%
72,7230.0%0.00%
Q2 2023$898,129
+52.6%
72,723
+14.7%
0.00%
Q1 2023$588,473
+17.2%
63,413
+32.6%
0.00%
Q4 2022$501,974
-41.1%
47,807
+1.7%
0.00%
Q3 2022$852,000
+39.7%
47,003
+9.3%
0.00%
Q2 2022$610,000
+79.9%
43,009
+179.7%
0.00%
Q1 2022$339,000
+68.7%
15,379
+30.1%
0.00%
Q4 2021$201,00011,8220.00%
Other shareholders
AURA BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,039,892$27,267,8318.71%
Decheng Capital Management III (Cayman), LLC 1,163,123$18,243,9286.09%
Regency Capital Management Inc.\DE 526,978$4,726,9934.02%
Matrix Capital Management Company, LP 5,362,870$48,104,9440.58%
Nantahala Capital Management 743,892$6,672,7110.57%
Eventide Asset Management 3,024,905$27,133,3980.49%
Rock Springs Capital Management LP 722,896$6,484,3770.17%
LEVIN CAPITAL STRATEGIES, L.P. 81,095$727,4220.09%
Long Focus Capital Management, LLC 195,175$1,750,7200.06%
Values First Advisors, Inc. 10,401$93,2990.06%
View complete list of AURA BIOSCIENCES INC shareholders